Efficacy of sacubitril/ valsartan in patients with heart failure following right ventricular myocardial infarction

被引：0
|
作者：
Stepanyan, A. Anna [1 ]
Hayrapetyan, H. [1 ]
Petrosyan, H. [1 ]
Safaryan, M. [1 ]
Poghosyan, H. [1 ]
Meloyan, V. [1 ]
机构：
[1] Erebouni Med Ctr, Yerevan, Armenia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1297
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [31] Tolerability and beneficial effects of sacubitril/valsartan on systemic right ventricular failure
    Nederend, Marieke
    Kies, Philippine
    Regeer, Madelien, V
    Vliegen, Hubert W.
    Mertens, Bart J. A.
    Robbers-Visser, Danielle
    Bouma, Berto J.
    Tops, Laurens F.
    Schalij, Martin J.
    Jongbloed, Monique R. M.
    Egorova, Anastasia D.
    HEART, 2023, 109 (20) : 1525 - 1532
  • [32] Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure
    Correale, Michele
    Mazzeo, Pietro
    Magnesa, Michele
    Fortunato, Martino
    Tricarico, Lucia
    Leopizzi, Alessandra
    Mallardi, Adriana
    Mennella, Raffaele
    Tucci, Salvatore
    Brunetti, Natale Daniele
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2021, 41 (06) : 505 - 513
  • [33] Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure
    Neijenhuis, Ralph M. L.
    Nederend, Marieke
    van Groningen, Anna E.
    Jongbloed, Monique R. M.
    Vliegen, Hubert W.
    Jukema, J. Wouter
    Kies, Philippine
    Egorova, Anastasia D.
    OPEN HEART, 2025, 12 (01):
  • [34] The combined effect of Sacubitril-valsartan treatment on right ventricular function and cardiorespiratory response in patients with chronic heart failure
    Chrysohoou, C.
    Terzis, I
    Xanthopoulou, M.
    Tzorovili, E.
    Konstantinou, C.
    Solomou, E.
    Magkas, N.
    Antoniou, C. K.
    Xydis, P.
    Dilaveris, P.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 922 - 922
  • [35] Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
    Bissessor, Naylin
    White, Harvey
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (04) : 425 - 430
  • [36] SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE
    Cooper, Lauren Beth
    Kaltenbach, Lisa
    Al-Khalidi, Hussein
    Cole, Robert
    Allen, Larry A.
    Fonarow, Gregg C.
    Butler, Javed
    Albert, Nancy M.
    Lanfear, David E.
    Granger, Bradi
    Kociol, Robb
    Pina, Ileana
    Heidenreich, Paul
    Granger, Christopher B.
    Felker, G. Michael
    Lewis, Eldrin
    McRae, Andrew
    Hernandez, Adrian
    DeVore, Adam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1063 - 1063
  • [37] Left Ventricular Function Improves in Heart Failure Patients Treated With Sacubitril-Valsartan
    Nazzari, Hamed
    Yeung, Michael
    Marceau, Aude
    Luong, Michael
    Clark, Catherine
    Ahuja, Stephanie
    Knoll, Jennifer
    Koscal, Mirka
    Davis, Margot
    Virani, Sean
    Ignaszewski, Andrew
    Toma, Mustafa
    CIRCULATION, 2017, 136
  • [38] Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure
    Vader, Justin M.
    Givertz, Michael M.
    Starling, Randall C.
    McNulty, Steven E.
    Anstrom, Kevin J.
    Desvigne-Nickens, Patrice
    Hernandez, Adrian F.
    Braunwald, Eugene
    Mann, Douglas L.
    JACC-HEART FAILURE, 2022, 10 (07) : 449 - 456
  • [39] Early Implementation of Sacubitril/Valsartan for Patients With Heart Failure
    Wilcox, Jane E.
    JAMA CARDIOLOGY, 2020, 5 (02) : 207 - 208
  • [40] Sacubitril/valsartan in patients with heart failure and a history of cancer
    Frey, M. K.
    Arfsten, H.
    Pavo, N.
    Han, E.
    Huelsmann, M.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S225 - S225
12345